<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04937075</url>
  </required_header>
  <id_info>
    <org_study_id>RC21_0066</org_study_id>
    <nct_id>NCT04937075</nct_id>
  </id_info>
  <brief_title>Impact of Antimicrobial Stewardship on Outcomes of Patients With Hospital-acquired Pneumonia Due to Gram-negative Bacilli - A Before-after Study</brief_title>
  <acronym>ORACLE</acronym>
  <official_title>Impact of Antimicrobial Stewardship on Outcomes of Patients With Hospital-acquired Pneumonia Due to Gram-negative Bacilli - A Before-after ORACLE Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hospital-acquired pneumonia (HAP) is one of the most frequent complications and the main&#xD;
      cause of antibiotics use in hospitalized patients, particularly in intensive care units&#xD;
      (ICUs). The latest European and French recommendations for the management of HAP were&#xD;
      published in 2017 and 2018. Gram-negative bacilli are frequently identified in this&#xD;
      pneumonia.&#xD;
&#xD;
      The experts discussed the issue of tailored-empiric antimicrobial therapy. Because delayed&#xD;
      antimicrobial therapy is associated with poor outcomes, their conclusion was to reduce the&#xD;
      time to deliver proper antimicrobial therapy, but to limit over-use of broad-spectrum&#xD;
      molecules. Since delays in microbiological identification hinder the ability of clinicians to&#xD;
      streamline therapy, rapid diagnostic with multiplex PCR, which decreases the time to organism&#xD;
      identification by 2 days compared to conventional methods, is appealing, especially for&#xD;
      gram-negative bacilli. The FilmArray® Lower Respiratory Tract Infection Panel is a rapid&#xD;
      multiplex PCR which tests for the most frequently pathogens (18 bacteria including plenty of&#xD;
      gram-negative bacilli +5 genes of resistance, and 9 viruses) involved in HAP. The FilmArray®&#xD;
      Lower Respiratory Tract Infection (LRTI) Panel has a sensitivity and a specificity of 95% and&#xD;
      99% respectively and can be implemented in a personalized antimicrobial guidance to treat HAP&#xD;
      due to gram-negative bacilli. The investigators hypothesized that a rapid multiplex PCR for&#xD;
      guidance of empiric antimicrobial therapy, especially for gram-negative bacilli, reduces the&#xD;
      time-to-proper antimicrobial therapy and reduces the risk of death of patients suffering of&#xD;
      HAP.&#xD;
&#xD;
      The investigators aim to assess the efficacy of an antimicrobial stewardship including the&#xD;
      results of a rapid respiratory panel multiplex PCR for empiric antimicrobial guidance in&#xD;
      patients with hospital-acquired pneumonia due to gram-negative bacilli.&#xD;
&#xD;
      The investigators will use a before-after design to test the efficiency of an antimicrobial&#xD;
      stewardship including a highly innovative intervention.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Crossover</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the effectiveness of access to empiric antibiotic therapy guided by Multiplex PCR in intensive care patients with hospital acquired pneumonia</measure>
    <time_frame>28 days</time_frame>
    <description>Composite endpoints: survival on D28, number of days without mechanical ventilation on D28, and clinical recovery between D7 and D10 (RADAR method)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Hospital-acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>Before period without multiplex PCR identification</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>After period with multiplex PCR identification</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>After period with multiplex PCR identification</arm_group_label>
    <arm_group_label>Before period without multiplex PCR identification</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The investigators will include 400 patients hospitalized in intensive care units, under&#xD;
        mechanical ventilation, with a suspected hospital-acquired pneumonia : 200 patients in the&#xD;
        retrospective &quot;before&quot; phase, 200 patients in the prospective &quot;after&quot; phase with the PCR&#xD;
        multiplex identification&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Immunocompetent adult patients&#xD;
&#xD;
          -  Receiving mechanical ventilation&#xD;
&#xD;
          -  Suspected hospital-acquired pneumonia&#xD;
&#xD;
          -  Non-opposition from the patient or a relative.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women, breastfeeding-women&#xD;
&#xD;
          -  Minors, Adults under guardianship or trusteeship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Antoine Roquilly</last_name>
    <phone>0253482230</phone>
    <email>antoine.roquilly@chu-nantes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Roquilly</last_name>
      <phone>0253482230</phone>
      <email>antoine.roquilly@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 31, 2021</study_first_submitted>
  <study_first_submitted_qc>June 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Healthcare-Associated Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

